Securing access for Cagrilintide 10mg and abaloparatide can be challenging, as they are specialty drugs primarily approved for osteoporosis care in people at significant risk for fractures. Generally, these injectable medications are not accessible over-the-counter and demand a medical authorization. A physician is the initial point of contact for